{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:43Z","timestamp":1740107743007,"version":"3.37.3"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10067-019-04911-9","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T21:02:28Z","timestamp":1579035748000},"page":"479-480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comment on \u201cImpact of TNF-\u0391 inhibitor on lipid profile and atherogenic index of plasma in axial spondyloarthritis: 2-year follow-up data from the catholic axial spondyloarthritis cohort (CASCO)\u201d"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7807-135X","authenticated-orcid":false,"given":"Erkan","family":"Cure","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medine","family":"Cumhur Cure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"4911_CR1","doi-asserted-by":"publisher","unstructured":"Min HK, Lee J, Ju JH, Park SH, Kwok SK (2019) Impact of TNF-\u03b1 inhibitor on lipid profile and atherogenic index of plasma in axial spondyloarthritis: 2-year follow-up data from the Catholic axial Spondyloarthritis COhort (CASCO). Clin Rheumatol 1\u20137. https:\/\/doi.org\/10.1007\/s10067-019-04767-z","DOI":"10.1007\/s10067-019-04767-z"},{"key":"4911_CR2","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s10067-018-4027-0","volume":"37","author":"E Cure","year":"2018","unstructured":"Cure E, Icli A, Uslu AU, Sakiz D, Cure MC, Baykara RA (2018) Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis: AIP associate with cIMT in AS. Clin Rheumatol 37:1273\u20131280","journal-title":"Clin Rheumatol"},{"key":"4911_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.curtheres.2018.07.001","volume":"89","author":"U Bergstr\u00f6m","year":"2018","unstructured":"Bergstr\u00f6m U, Jovinge S, Persson J, Jacobsson LTH, Turesson C (2018) Effects of treatment with adalimumab on blood lipid levels and atherosclerosis in patients with rheumatoid arthritis. Curr Ther Res Clin Exp 89:1\u20136","journal-title":"Curr Ther Res Clin Exp"},{"key":"4911_CR4","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10067-010-1405-7","volume":"29","author":"EN Pollono","year":"2010","unstructured":"Pollono EN, Lopez-Olivo MA, Lopez JA, Suarez-Almazor ME (2010) A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis. Clin Rheumatol 29:947\u2013955","journal-title":"Clin Rheumatol"},{"key":"4911_CR5","first-page":"921","volume":"33","author":"DN Kiortsis","year":"2006","unstructured":"Kiortsis DN, Mavridis AK, Filippatos TD, Vasakos S, Nikas SN, Drosos AA (2006) Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 33:921\u2013923","journal-title":"J Rheumatol"},{"key":"4911_CR6","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s10067-017-3537-5","volume":"36","author":"JR Maneiro","year":"2017","unstructured":"Maneiro JR, Souto A, Gomez-Reino JJ (2017) Impact of treatment with TNF antagonists on total cholesterol in patients with ankylosing spondylitis and psoriatic arthritis. Clin Rheumatol 36:1167\u20131172","journal-title":"Clin Rheumatol"},{"key":"4911_CR7","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1007\/s10067-017-3623-8","volume":"36","author":"DG Maia","year":"2017","unstructured":"Maia DG, Augusto KL, Bezerra MC, Rodrigues CEM (2017) Metabolic syndrome in patients with ankylosing spondylitis receiving anti-TNF\u03b1 therapy: association with predictors of cardiovascular risk. Clin Rheumatol 36:2371\u20132376","journal-title":"Clin Rheumatol"},{"key":"4911_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00393-016-0092-4","volume":"76","author":"A Kucuk","year":"2017","unstructured":"Kucuk A, U\u011fur Uslu A, Icli A, Cure E, Arslan S, Turkmen K, Toker A, Kayrak M (2017) The LDL\/HDL ratio and atherosclerosis in ankylosing spondylitis. Z Rheumatol 76:58\u201363","journal-title":"Z Rheumatol"},{"key":"4911_CR9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/jrms.JRMS_869_17","volume":"23","author":"M Karimifar","year":"2018","unstructured":"Karimifar M, Sepehrifar MS, Moussavi H, Sepehrifar MB, Mottaghi P, Siavash M et al (2018) The effects of conventional drugs in the treatment of rheumatoid arthritis on the serum lipids. J Res Med Sci 23:105","journal-title":"J Res Med Sci"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04911-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04911-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04911-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T03:27:21Z","timestamp":1695612441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04911-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["4911"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04911-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2020,1,14]]},"assertion":[{"value":"14 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}